Log in

Concert Pharmaceuticals SEC Filings & 10K Form (NASDAQ:CNCE)

$11.05
-0.06 (-0.54 %)
(As of 02/23/2020 03:05 AM ET)
Today's Range
$11.02
Now: $11.05
$11.45
50-Day Range
$9.26
MA: $10.67
$13.09
52-Week Range
$5.36
Now: $11.05
$17.83
Volume75,386 shs
Average Volume214,790 shs
Market Capitalization$326.86 million
P/E RatioN/A
Dividend YieldN/A
Beta1.05

SEC Filings

Concert Pharmaceuticals (NASDAQ:CNCE) SEC Filings

DateFilerForm TypeView
02/14/2020
2:13 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
11:57 AM
BANK OF AMERICA CORP /DE/ (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G
02/12/2020
9:43 AM
Concert Pharmaceuticals (Subject)
DIMENSIONAL FUND ADVISORS LP (Filed by)
Form SC 13G
02/10/2020
1:19 PM
BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2020
12:34 PM
Arkin Moshe (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G
02/05/2020
10:26 AM
BlackRock Inc. (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
02/04/2020
10:30 AM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
3:46 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2020
5:13 AM
Concert Pharmaceuticals (Filer)
Form 424B5
01/23/2020
1:21 PM
Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SC 13G/A
01/22/2020
8:52 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2019
3:05 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
3:05 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
6:06 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
6:03 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
5:45 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2019
7:58 AM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:37 PM
Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2019
3:34 PM
Concert Pharmaceuticals (Issuer)
Munsie Jeffrey A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2019
3:01 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2019
5:20 AM
Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
5:18 AM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
5:12 AM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
3:00 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
6:38 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2019
6:36 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
2:31 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
06/17/2019
8:14 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:07 PM
Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:06 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:05 PM
Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:03 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:02 PM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
8:01 PM
Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
3:37 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2019
3:16 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:14 PM
Concert Pharmaceuticals (Issuer)
Hoeiland Jesper (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/02/2019
6:27 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
6:26 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
6:23 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
6:22 AM
Concert Pharmaceuticals (Filer)
Form DEF 14A
04/24/2019
3:27 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
3:34 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
3:15 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2019
2:17 PM
BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
Concert Pharmaceuticals (Issuer)
LAMPERT MARK N (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/02/2019
1:50 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
03/01/2019
3:43 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
6:26 AM
Concert Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2019
6:22 AM
Concert Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2019
6:08 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2019
4:17 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G
02/07/2019
4:11 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Concert Pharmaceuticals (Subject)
Form SC 13G/A
02/07/2019
3:35 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2019
7:46 AM
Concert Pharmaceuticals (Subject)
INGALLS & SNYDER LLC (Filed by)
Form SC 13G/A
01/08/2019
3:10 PM
Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:09 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:08 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:07 PM
Becker Marc A. (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2019
3:06 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2018
5:56 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2018
3:08 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/23/2018
3:00 PM
Concert Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G
11/19/2018
4:27 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2018
4:22 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2018
4:21 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2018
6:33 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2018
6:28 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2018
6:30 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/02/2018
6:27 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2018
3:04 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
6:01 PM
Concert Pharmaceuticals (Issuer)
JAEGER WILFRED E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
6:00 PM
Concert Pharmaceuticals (Issuer)
WIERENGA WENDALL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:59 PM
Concert Pharmaceuticals (Issuer)
HUTT PETER BARTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:58 PM
Concert Pharmaceuticals (Issuer)
Fitzgerald Meghan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:57 PM
Barrett Ronald W (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:57 PM
Concert Pharmaceuticals (Issuer)
van Heek Christi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:56 PM
Auchincloss Thomas G (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
5:55 PM
ALDRICH RICHARD (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
3:05 PM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/12/2018
3:56 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2018
6:37 AM
Concert Pharmaceuticals (Filer)
Form DEF 14A
05/03/2018
6:33 AM
Concert Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2018
6:30 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2018
3:07 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2018
3:51 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4/A
04/13/2018
3:50 PM
Concert Pharmaceuticals (Issuer)
HERSCHA LYNETTE (Reporting)
Form 4/A
04/13/2018
3:47 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4/A
04/13/2018
3:46 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4/A
04/10/2018
7:00 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2018
3:22 PM
Concert Pharmaceuticals (Issuer)
Lynch Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:21 PM
Concert Pharmaceuticals (Issuer)
Stuart Nancy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:20 PM
Cassella James V (Reporting)
Concert Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2018
3:19 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/22/2018
3:06 PM
Concert Pharmaceuticals (Filed by)
Processa Pharmaceuticals, Inc. (Subject)
Form SC 13G
03/07/2018
11:15 PM
Concert Pharmaceuticals (Filer)
Form EFFECT
03/05/2018
3:29 PM
Concert Pharmaceuticals (Issuer)
Tung Roger D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2018
6:41 AM
Concert Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/01/2018
6:38 AM
Concert Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/01/2018
6:34 AM
Concert Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/01/2018
6:31 AM
Concert Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Featured Article: Float

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel